Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by muscle weakness and caused by pathogenic autoantibodies that bind to membrane proteins at the neuromuscular junction. Most patients have autoantibodies against the acetylcholine receptor (AChR), but a subset of patients have au...
Main Authors: | Takata, K, Stathopoulos, P, Cao, M, Mané-Damas, M, Fichtner, M, Benotti, E, Jacobson, L, Waters, P, Irani, S, Martinez-Martinez, P, Beeson, D, Losen, M, Vincent, A, Nowak, R, O'Connor, K |
---|---|
פורמט: | Journal article |
יצא לאור: |
American Society for Clinical Investigation
2019
|
פריטים דומים
-
Diagnostic use of autoantibodies in myasthenia gravis.
מאת: Leite, M, et al.
יצא לאור: (2010) -
Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy
מאת: Miriam L. Fichtner, et al.
יצא לאור: (2022-10-01) -
Silencing of Dok-7 in adult rat muscle increases susceptibility to passive transfer myasthenia gravis
מאת: Gomez, A, et al.
יצא לאור: (2016) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
מאת: Miriam L Fichtner, et al.
יצא לאור: (2022-01-01) -
Myasthenia gravis complement activity is independent of autoantibody titer and disease severity
מאת: Miriam L. Fichtner, et al.
יצא לאור: (2022-01-01)